Fulgent Genetics, Inc.
Fulgent Genetics, Inc. scores highest on Torque (73) and lowest on Earnings (41). Its PosiPenta is 57.44 out of 100, around the middle of similar companies.
On the Penta Grid this week, Fulgent Genetics, Inc. is Grid #173 of 836 in the Healthcare sector in United States, and Grid #921 of 3,999 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Fulgent Genetics, Inc. | 57.44 | 45 | 41 | 64 | 73 | 64 |
| Aclaris Therapeutics, Inc. | 42.60 | 17 | 37 | 53 | 57 | 49 |
| Shattuck Labs, Inc. | 49.85 | 24 | 41 | 71 | 64 | 49 |
| Myriad Genetics, Inc. | 43.34 | 36 | 51 | 46 | 42 | 41 |
| Electra Therapeutics, Inc. | 35.43 | 0 | 26 | 41 | 68 | 42 |
| Olema Pharmaceuticals, Inc. | 33.98 | 35 | 24 | 13 | 62 | 36 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -7.05 |
| P/B ratio | 0.54 |
EEarnings
| Trailing EPS | ₹-266.15 |
| Forward EPS | ₹-130.71 |
NNitro
| Price | 1876.30 |
| 52-week high | 2939.95 |
| 52-week low | 1274.86 |
| Fall from 52-week high | 36.2% |
TTorque
| Return on equity (ROE) | -8.11% |
| Debt-to-equity | 0.01 |
AAnchor
| Beta (price swings) | 0.93 |
| Market cap | ₹5,162 Cr |
| Insider holding | 37.75% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Fulgent Genetics, Inc.'s PosiPenta score?
Fulgent Genetics, Inc.'s PosiPenta is 57.44 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Fulgent Genetics, Inc. stand on the Penta Grid?
On the Penta Grid this week, Fulgent Genetics, Inc. is Grid #173 of 836 in the Healthcare sector in United States, and Grid #921 of 3,999 in United States.
Which PosiPenta pillar is strongest for Fulgent Genetics, Inc.?
Torque (durability), with a score of 73 out of 100: better than most similar companies.
Which PosiPenta pillar is weakest for Fulgent Genetics, Inc.?
Earnings (growth), with a score of 41 out of 100: around the middle of similar companies.
Has Fulgent Genetics, Inc.'s PosiPenta changed since last week?
Yes, it rose 1.92 points, from 55.52 to 57.44.
PositoAI is for research and education only and is not investment advice.